FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1985492007> ?p ?o ?g. }

• W1985492007 endingPage "310" @default.
• W1985492007 startingPage "301" @default.
• W1985492007 abstract "Blood transfusions represent a main component of supportive care in myelodysplastic syndromes (MDS). To avoid organ damage caused by transfusion-dependent iron overload, an adequate iron chelation therapy is required. Recently, a new oral iron chelator deferasirox (ICL670, Exjade) has become available. A study was conducted to demonstrate the efficacy and tolerability of deferasirox in transfusion-dependent iron-overloaded patients with MDS. The efficacy of deferasirox was monitored by changes in serum ferritin, bone marrow iron, and liver iron concentration (LIC), as determined by T2*-weighted magnetic resonance imaging. Twelve patients with MDS of different subtypes (median age 76 years, range 53-91) were enrolled. Deferasirox administered in a once-daily dose of 20-30 mg/kg for 12 months was effective in reducing median ferritin concentration from 1,515 microg/L (range 665-6,900) to 413 microg/L (range 105-3,052). Within the first 4 weeks of treatment before the continuous decline of ferritin levels, the values markedly rose in eight of 12 patients. The median LIC declined from 315 to 230 micromol/g (p=0.02) at the end of study, accompanied by a reduction of bone marrow siderosis. The most common adverse events were mild and transient gastrointestinal disturbances, skin rash, nonprogressive transient increases in serum creatinine and urine beta2-microglobulin, and a temporary reduction of the creatinine clearance. The renal parameters normalized after end of treatment. No hematologic toxicities were observed. Deferasirox proved to be effective in transfusion-dependent iron overload in MDS by mobilizing iron deposits in liver and at least stabilizing iron stores in bone marrow." @default.
• W1985492007 created "2016-06-24" @default.
• W1985492007 creator A5003016730 @default.
• W1985492007 creator A5016147985 @default.
• W1985492007 creator A5038769308 @default.
• W1985492007 creator A5040836871 @default.
• W1985492007 creator A5057064226 @default.
• W1985492007 creator A5063819132 @default.
• W1985492007 creator A5078745756 @default.
• W1985492007 creator A5084801082 @default.
• W1985492007 date "2008-08-29" @default.
• W1985492007 modified "2023-09-25" @default.
• W1985492007 title "Deferasirox in MDS patients with transfusion-caused iron overload—a phase-II study" @default.
• W1985492007 cites W1963682535 @default.
• W1985492007 cites W1967657836 @default.
• W1985492007 cites W1969640272 @default.
• W1985492007 cites W1973162291 @default.
• W1985492007 cites W1977937770 @default.
• W1985492007 cites W1980848748 @default.
• W1985492007 cites W1988173388 @default.
• W1985492007 cites W1995149316 @default.
• W1985492007 cites W1995162700 @default.
• W1985492007 cites W1995812599 @default.
• W1985492007 cites W2005746290 @default.
• W1985492007 cites W2005969591 @default.
• W1985492007 cites W2009553907 @default.
• W1985492007 cites W2018131656 @default.
• W1985492007 cites W2018938097 @default.
• W1985492007 cites W2039715247 @default.
• W1985492007 cites W2041555482 @default.
• W1985492007 cites W2054305599 @default.
• W1985492007 cites W2060225015 @default.
• W1985492007 cites W2061877295 @default.
• W1985492007 cites W2062187126 @default.
• W1985492007 cites W2067697375 @default.
• W1985492007 cites W2069553612 @default.
• W1985492007 cites W2071208608 @default.
• W1985492007 cites W2071843143 @default.
• W1985492007 cites W2100714931 @default.
• W1985492007 cites W2101019397 @default.
• W1985492007 cites W2119692077 @default.
• W1985492007 cites W2121230873 @default.
• W1985492007 cites W2128335522 @default.
• W1985492007 cites W2131817786 @default.
• W1985492007 cites W2133410277 @default.
• W1985492007 cites W2140633388 @default.
• W1985492007 cites W2149746557 @default.
• W1985492007 cites W2156237444 @default.
• W1985492007 cites W2163003062 @default.
• W1985492007 cites W2331162460 @default.
• W1985492007 cites W3036602249 @default.
• W1985492007 cites W4360894011 @default.
• W1985492007 doi "https://doi.org/10.1007/s00277-008-0588-3" @default.
• W1985492007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18758781" @default.
• W1985492007 hasPublicationYear "2008" @default.
• W1985492007 type Work @default.
• W1985492007 sameAs 1985492007 @default.
• W1985492007 citedByCount "54" @default.
• W1985492007 countsByYear W19854920072012 @default.
• W1985492007 countsByYear W19854920072013 @default.
• W1985492007 countsByYear W19854920072014 @default.
• W1985492007 countsByYear W19854920072015 @default.
• W1985492007 countsByYear W19854920072016 @default.
• W1985492007 countsByYear W19854920072017 @default.
• W1985492007 countsByYear W19854920072018 @default.
• W1985492007 countsByYear W19854920072020 @default.
• W1985492007 countsByYear W19854920072021 @default.
• W1985492007 crossrefType "journal-article" @default.
• W1985492007 hasAuthorship W1985492007A5003016730 @default.
• W1985492007 hasAuthorship W1985492007A5016147985 @default.
• W1985492007 hasAuthorship W1985492007A5038769308 @default.
• W1985492007 hasAuthorship W1985492007A5040836871 @default.
• W1985492007 hasAuthorship W1985492007A5057064226 @default.
• W1985492007 hasAuthorship W1985492007A5063819132 @default.
• W1985492007 hasAuthorship W1985492007A5078745756 @default.
• W1985492007 hasAuthorship W1985492007A5084801082 @default.
• W1985492007 hasBestOaLocation W19854920072 @default.
• W1985492007 hasConcept C126322002 @default.
• W1985492007 hasConcept C141071460 @default.
• W1985492007 hasConcept C153852466 @default.
• W1985492007 hasConcept C197934379 @default.
• W1985492007 hasConcept C2776517179 @default.
• W1985492007 hasConcept C2776672577 @default.
• W1985492007 hasConcept C2777417653 @default.
• W1985492007 hasConcept C2777799968 @default.
• W1985492007 hasConcept C2778248108 @default.
• W1985492007 hasConcept C2778319317 @default.
• W1985492007 hasConcept C2778375690 @default.
• W1985492007 hasConcept C2780007613 @default.
• W1985492007 hasConcept C2780306776 @default.
• W1985492007 hasConcept C2780817109 @default.
• W1985492007 hasConcept C2780883591 @default.
• W1985492007 hasConcept C2781053155 @default.
• W1985492007 hasConcept C71924100 @default.
• W1985492007 hasConcept C90924648 @default.
• W1985492007 hasConceptScore W1985492007C126322002 @default.
• W1985492007 hasConceptScore W1985492007C141071460 @default.
• W1985492007 hasConceptScore W1985492007C153852466 @default.

• next